First-trimester screening for aneuploidy.
Prenatal screening for aneuploidy in the first trimester using novel ultrasound and maternal serum markers represents a promising improvement over the currently available second-trimester screening methods. This article reviews the current status of first-trimester screening for Down syndrome and other aneuploidies and explores the issues related to implementing first-trimester screening into mainstream prenatal care in the United States.
['*Aneuploidy', 'Biomarkers/blood', 'Blood Flow Velocity', 'Down Syndrome/*diagnostic imaging', 'Female', 'Humans', 'Liver/blood supply/embryology', '*Mass Screening', 'Nasal Bone/embryology', 'Neck/diagnostic imaging/embryology', 'Pregnancy', 'Pregnancy Trimester, First', 'Pregnancy, Multiple', '*Ultrasonography, Prenatal', 'Umbilical Veins/physiology', 'Vena Cava, Inferior/embryology']